GregoryDavidHuhnMD

PubMed

• 18 citations
  Excess weight gain with integrase inhibitors and tenofovir alafenamide: what is the mechanism and does it matter?
  Brian R. Wood, Gregory Huhn> ;Open Forum Infectious Diseases. 2021 Nov 17
• 19 citations
  A randomized, placebo-controlled clinical trial of bamlanivimab and etesevimab together in high-risk ambulatory patients with COVID-19 and validation of the prognostic...
  Michael Dougan, Masoud Azizad, Bharat Mocherla, Robert L. Gottlieb, Peter Chen, Corey Hebert, Russell Perry, Joseph Boscia, Barry Heller, Jason Morris, Chad Crystal, A...> ;Clinical Infectious Diseases. 2021 Oct 28
• 3 citations
  Week 96 subgroup analyses of the phase 3, randomized AMBER and EMERALD trials evaluating the efficacy and safety of the once daily darunavir/cobicistat/emtricitabine/t...
  Gregory D Huhn, Aimee M. Wilkin, Cristina Mussini, Christoph D. Spinner, John Jezorwski, Mohsine El Ghazi, Erika Van Landuyt, Erkki Lathouwers, Kimberley Brown, Bryan ...> ;HIV Research & Clinical Practice. 2020 Nov 1
• 827 citations
  SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19.
  Peter Chen, Ajay Nirula, Barry Heller, Robert L. Gottlieb, Joseph Boscia, Jason Morris, Gregory D. Huhn, Jose Cardona, Bharat Mocherla, Valentina Stosor, Imad Shawa, A...> ;The New England Journal of Medicine. 2021 Jan 21
• 641 citations
  Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
  Robert L. Gottlieb, Ajay Nirula, Peter Chen, Joseph Boscia, Barry Heller, Jason Morris, Gregory D. Huhn, Jose Cardona, Bharat Mocherla, Valentina Stosor, Imad Shawa, P...> ;JAMA. 2021 Feb 16
• 18 citations
  Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Rapid-Initiation Model of Care for Human Immunodeficiency Virus Type 1 Infection: Primary Analysis of the...
  Gregory D Huhn, Gordon Crofoot, Moti Ramgopal, Joseph Gathe, Robert K. Bolan, Donghan Luo, Richard Bruce Simonson, Richard E. Nettles, Carmela Benson, Keith Dunn> ;Clinical Infectious Diseases. 2020 Dec 15
• 7 citations
  A Novel Score to Predict Esophageal Varices in Patients with Compensated Advanced Chronic Liver Disease.
  Vikram Kotwal, Chimezie Mbachi, Yuchen Wang, Bashar M. Attar, Tejinder Randhawa, Estefania Flores, Julian Robles, Craig Rosenstengle, Melchor Demetria, Oluwatoyin Adey...> ;Digestive Diseases and Sciences. 2021 Jun 1
• 24 citations
  Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCV
  Sonia Vibhakar Patel, Dushyantha Jayaweera, Keri N. Althoff, Joseph J. Eron, Janna Radtchenko, Anthony Mills, Graeme Moyle, Steven Santiago, Paul E. Sax, Jason Gillman...> ;Plos One. 2020 Feb 13
• 3 citations
  HIV/HCV therapy with ledipasvir/sofosbuvir after randomized switch to emtricitabine-tenofovir alafenamide-based single-tablet regimens.
  Gregory D Huhn, Moti Ramgopal, Mamta K. Jain, Federico Hinestrosa, David M. Asmuth, Jihad Slim, Deborah Goldstein, Shauna Applin, Julie H. Ryu, Shuping Jiang, Stephani...> ;Plos One. 2020 Jan 29
• 23 citations
  Atherosclerotic Cardiovascular Disease Risk Profile of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate
  Gregory D Huhn, David Shamblaw, Jean-Guy Baril, Priscilla Y. Hsue, Brittany L Mills, Thai Nguyen-Cleary, Scott McCallister, Moupali Das> ;Open Forum Infectious Diseases. 2020 Jan 1
• 7 citations
  Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-experienced, virologically suppressed patients with HIV-1: subgroup analyses of the phase 3 EMERA...
  Gregory D Huhn, Joseph J. Eron, Pierre-Marie Girard, Chloe Orkin, Jean-Michel Molina, Edwin DeJesus, Romana Petrovic, Donghan Luo, Erika Van Landuyt, Erkki Lathouwers,...> ;AIDS Research and Therapy. 2019 Aug 29
• 7 citations
  Pharmacokinetics of tenofovir monoester and association with intracellular tenofovir diphosphate following single-dose tenofovir disoproxil fumarate.
  Kristina M Brooks, Mustafa E Ibrahim, Jose R Castillo-Mancilla, Samantha MaWhinney, Keisha Alexander, Scott G. Tilden, Becky Jo Kerr, Lucas Ellison, Cricket McHugh, La...> ;The Journal of Antimicrobial Chemotherapy. 2019 Aug 1
• 11 citations
  Steatosis Rates by Liver Biopsy and Transient Elastography With Controlled Attenuation Parameter in Clinical Experience of Hepatitis C Virus (HCV) and Human Immunodefi...
  Sarah Sansom, Jonathan Martin, Oluwatoyin Adeyemi, Kerianne Burke, Crystal Winston, Sara Markham, Benjamin Go, Gregory Huhn> ;Open Forum Infectious Diseases. 2019 Mar 1
• 12 citations
  Short Communication: Bioequivalence of Tenofovir and Emtricitabine After Coencapsulation with the Proteus Ingestible Sensor
  Mustafa E Ibrahim, Kristina M Brooks, Jose R Castillo-Mancilla, Cricket McHugh, Mary Morrow, Samantha MaWhinney, Sybil G. Hosek, Gregory D Huhn, Peter L. Anderson> ;AIDS Research and Human Retroviruses. 2018 Oct 12
• 16 citations
  Contribution of Liver Fibrosis and Microbial Translocation to Immune Activation in Persons Infected With HIV and/or Hepatitis C Virus
  Michael J. A. Reid, Yifei Ma, Rebecca Scherzer, Jennifer C. Price, Audrey L. French, Gregory Huhn, Michael Plankey, Marion G. Peters, Carl Grunfeld, Phyllis C. Tien> ;The Journal of Infectious Diseases. 2018 Mar 28
• 9 citations
  Daclatasvir and sofosbuvir with ribavirin for 24 weeks in chronic hepatitis C genotype-3-infected patients with cirrhosis: a Phase III study (ALLY-3C).
  Fred Poordad, Mitchell L. Shiffman, Wayne Ghesquiere, Alexander Wong, Gregory D Huhn, Florence Wong, Alnoor Ramji, Stephen D. Shafran, Fiona McPhee, Rong Yang, Stephan...> ;Antiviral Therapy. 2018 Jan 1
• 44 citations
  A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infec...
  Gregory D Huhn, Pablo Tebas, Joel E. Gallant, Timothy J. Wilkin, Andrew K. Cheng, Mingjin Yan, Lijie Zhong, Christian Callebaut, Joseph M. Custodio, Marshall W. Fordyc...> ;Journal of Acquired Immune Deficiency Syndromes. 2017 Feb 1
• 24 citations
  Nephrotoxicity Associated with Concomitant Use of Ledipasvir‐Sofosbuvir and Tenofovir in a Patient with Hepatitis C Virus and Human Immunodeficiency Virus Coinfection
  Kristen L. Bunnell, Sonia Vibhakar, Robert C. Glowacki, Maureen Gallagher, Albert M. Osei, Gregory D Huhn> ;Pharmacotherapy. 2016 Sep 1
• 237 citations
  Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised...
  Anthony Mills, Jose R. Arribas, Jaime Andrade-Villanueva, Giovanni DiPerri, Jan van Lunzen, Ellen Koenig, Richard Elion, Matthias Cavassini, Jose V aldez Madruga, Jaso...> ;The Lancet. Infectious Diseases. 2016 Jan 1
• 2 citations
  Simplification from twice-daily to once-daily darunavir/ritonavir in a randomized trial among HIV-infected persons with HIV-1 RNA suppression on antiretroviral therapy.
  Gregory D Huhn, Andrew Sigman, Britt Livak> ;Antiviral Therapy. 2015 Jan 1
• 18 citations
  A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection.
  Aimee C. Hodowanec, Rebecca D. Lee, Kirsten E. Brady, Weihua Gao, Stacey L. Kincaid, Jill Plants, Mieoak Bahk, Nigel Mackman, Alan L. Landay, Gregory Huhn> ;BMC Infectious Diseases. 2015 Apr 17
• 19 citations
  Characterization of CD4⁺ T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patients.
  Aimee C. Hodowanec, Kirsten E. Brady, Weihua Gao, Stacey L. Kincaid, Jill Plants, Mieoak Bahk, Alan L. Landay, Gregory Huhn> ;Journal of Acquired Immune Deficiency Syndromes. 2013 Nov 1
• 15 citations
  Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naï...
  Princy Kumar, Edwin DeJesus, Gregory D Huhn, Louis Sloan, Catherine B. Small, Howard Edelstein, Franco Felizarta, Ritche Hao, Lisa L. Ross, Britt Stancil, Keith A. Pap...> ;BMC Infectious Diseases. 2013 Jun 7
• Providers' lack of knowledge about herpes zoster in HIV-infected patients is among barriers to herpes zoster vaccination.
  Aziz, M.,Kessler, H.,Huhn, G.> ;Int J STD AIDS. 2013 Jun
• 3 citations
  Phaeomycotic cysts caused by Phoma species
  Shawn Vasoo, Lee Kien Yong, Priyanka Sultania-Dudani, Mary Lou Scorza, Marin Sekosan, Kathleen G. Beavis, Gregory D. Huhn> ;Diagnostic Microbiology and Infectious Disease. 2011 Aug 1
• Join now to see all

Journal Articles

• Effect of Bamlanivimab as Monotherapy or in Combination with Etesevimab on Viral Load in Patients with Mild to Moderate COVID-19  
  Barry Heller, Gregory Huhn, Valentina Stosor, Imad Shawa, JAMA
• SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19  
  Robert L Gottlieb, Joseph Boscia, Gregory Huhn, Valentina Stosor, Imad Shawa, The New England Journal of Medicine
• SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19  
  Robert L Gottlieb, Joseph Boscia, Gregory Huhn, Valentina Stosor, Imad Shawa, The New England Journal of Medicine
• Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19  
  Robert L Gottlieb, Gerard J Criner, Onyema Ogbuagu, Kathleen M Mullane, Anuj Gaggar, Diana M Brainard, Gregory Huhn, JAMA
• Daclatasvir and Sofosbuvir with Ribavirin for 24 Weeks in Chronic Hepatitis C Genotype-3-Infected Patients with Cirrhosis: A Phase III Study (ALLY-3C)  
  Mitchell L Shiffman, Stephanie Noviello, Gregory D Huhn, Antiviral Therapy
• Join now to see all